Lifestance Health Group Inc
General ticker "LFST" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $2.8B
Lifestance Health Group Inc follows the US Stock Market performance with the rate: 17.7%.
Estimated limits based on current volatility of 2.5%: low 7.06$, high 7.43$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.53$, 10.36$]
- 2024-12-30 to 2025-12-30 estimated range: [6.16$, 11.30$]
Financial Metrics affecting the LFST estimates:
- Negative: Non-GAAP EPS, $ of -0.51 <= 0.10
- Negative: Operating profit margin, % of -15.19 <= 1.03
- Negative: Operating cash flow per share per price, % of -0.65 <= 2.35
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Positive: 1.31 < Industry earnings per price (median), % of 1.35
- Negative: Industry operating profit margin (median), % of 0.95 <= 2.14
- Positive: Inventory ratio change, % of 0 <= 0
Short-term LFST quotes
Long-term LFST plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $667.51MM | $859.54MM | $1,055.66MM |
| Operating Expenses | $953.86MM | $1,069.72MM | $1,244.80MM |
| Operating Income | $-286.35MM | $-210.17MM | $-189.13MM |
| Non-Operating Income | $-46.75MM | $-22.56MM | $-17.45MM |
| Interest Expense | $38.91MM | $19.93MM | $21.22MM |
| Income(Loss) | $-333.11MM | $-232.73MM | $-206.58MM |
| Taxes | $-25.91MM | $-17.17MM | $-20.32MM |
| Profit(Loss) | $-307.20MM | $-215.56MM | $-186.26MM |
| Stockholders Equity | $1,545.03MM | $1,518.72MM | $1,428.93MM |
| Inventory | $38.07MM | $0.00MM | $0.00MM |
| Assets | $1,927.11MM | $2,173.87MM | $2,233.21MM |
| Operating Cash Flow | $9.42MM | $52.79MM | $-16.88MM |
| Capital expenditure | $94.49MM | $79.25MM | $40.52MM |
| Investing Cash Flow | $-194.08MM | $-139.46MM | $-60.34MM |
| Financing Cash Flow | $313.86MM | $47.26MM | $47.43MM |
| Earnings Per Share* | $-0.94 | $-0.61 | $-0.51 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.